Login
Toggle navigation
Videos
Categories
Trending
Sample Video
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Sample Video
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Old Mutual Launches 2023 Savings and Investment Monitor | Iain Williamson, CEO , Old Mutual Limited.
00:10:00
Mirvac Group (ASX:MGR): Susan Lloyd-Hurwitz, Leading the Way as Managing Director & CEO
00:10:00
Renewable Energy CEO Xavier Barbaro Discusses Europe's Ambition, Challenges, and the Path Forward | Xavier Barbaro, CEO, Neoen SA.
00:10:00
DRIVING SUSTAINABLE SOLUTIONS FOR BRAZIL’S ENERGY SECTOR|Marcelo Eduardo Martins,Vice-Chairman AT Cosan
00:10:00
Inner Core's Breakthrough: Converting Industrial Waste Gases into Clean Energy
00:10:00
Peter Podesser Presents SFC Energy's Role in Advancing Fuel Cell Technology for Clean Energy Solutions.
00:10:00
Max Tuesley Talks Lana Corina Copper Project and Future Plans at Mines and Money London | Max Tuesley, Managing Director , Culpeo Mineral Plc.
00:10:00
Sierra Metals: Expanding Operations and Strategic Plans for Growth
00:10:00
Customized Wealth Management for Your Life and Legacy
00:10:00
Locaweb’s Fernando Cirne Attributes Success to Pre-Crisis Growth Strategies | Fernando Cirne, CEO , Locaweb Serviços De Internet SA.
00:10:00
Kevin Leung of Haitong International Securities discusses the rationale behind China Depositary Receipts, while First Solar CEO Mark addresses related industry insights.
00:10:00
Introduction to Trek Metals Limited